Voya Investment Management LLC Sells 164 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Voya Investment Management LLC cut its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,567 shares of the medical instruments supplier’s stock after selling 164 shares during the period. Voya Investment Management LLC’s holdings in Mesa Laboratories were worth $207,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of MLAB. Barclays PLC grew its position in Mesa Laboratories by 357.4% in the third quarter. Barclays PLC now owns 8,837 shares of the medical instruments supplier’s stock valued at $1,148,000 after acquiring an additional 6,905 shares during the period. Franklin Resources Inc. lifted its stake in Mesa Laboratories by 27.8% in the third quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier’s stock valued at $828,000 after buying an additional 1,403 shares during the period. JPMorgan Chase & Co. lifted its stake in Mesa Laboratories by 29.3% in the third quarter. JPMorgan Chase & Co. now owns 8,406 shares of the medical instruments supplier’s stock valued at $1,092,000 after buying an additional 1,906 shares during the period. Pacer Advisors Inc. increased its holdings in shares of Mesa Laboratories by 4.3% in the fourth quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier’s stock worth $231,000 after acquiring an additional 73 shares in the last quarter. Finally, Berry Wealth Group LP grew its holdings in shares of Mesa Laboratories by 5.3% during the fourth quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier’s stock worth $219,000 after buying an additional 83 shares in the last quarter. 90.60% of the stock is currently owned by institutional investors.

Mesa Laboratories Stock Down 0.8%

MLAB stock opened at $126.94 on Wednesday. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. The business has a 50 day moving average price of $118.81 and a two-hundred day moving average price of $126.57. The company has a market cap of $689.79 million, a price-to-earnings ratio of -2.74 and a beta of 0.97. Mesa Laboratories, Inc. has a twelve month low of $83.68 and a twelve month high of $155.12.

Mesa Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, May 30th. This represents a $0.64 annualized dividend and a yield of 0.50%. Mesa Laboratories’s payout ratio is currently -1.38%.

Insider Buying and Selling at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the company’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the sale, the chief executive officer now owns 43,337 shares in the company, valued at approximately $5,369,887.67. The trade was a 32.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 4.40% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.